Anti-Methylglyoxal Monoclonal Antibody
(Anti MG monoclonal antibody, specific for argpyrimidine, clone
#3C)
(Catalog #MMG-030 for 30 microgram vial)
What is Methylglyoxal ?
Methylglyoxal (MG), an endogenous
metabolite that increases in diabetes and a common intermediate
in the Maillard reaction (glycation), reacts with proteins and forms
advanced glycation end products (AGE). MG reacts with arginine residue
in protein and forms numerous numbers of adducts, such as argpyrimidine.
This antibody is specific for argpyrimidine: N-(5-hydroxy-4,6-dimethylpyrimidine-2-yl)-L-ornithine.

Clone # |
: |
3C |
Antigen |
: |
MG-modified keyhole-lympet hemocyanine |
Specificity |
: |
Specific for MG-modified protein (especially Argpyrimidine) |
Subclass |
: |
Mouse IgG2a |
Form |
: |
Protein A purified. |
Application |
: |
Immunohistochemistry?It is recommended that the
antibody |
Storage |
: |
Less than -20°C |
Specificity of anti MG antibody.


Immunohistochemical detection of MG adducts in atherosclerotic aorta.
Noriyuki Shibata et al. Tokyo Women’s medical University
IMMUNOHISTOCHEMISTRY Procedure |
|
1) |
Paraffin sections were deparaffinized and rehydrated. |
2) |
Sections were quenched for several minutes with 3% hydrogen
|
3) |
Antigen retrieval by microwave treatment. |
4) |
Sections were incubated overnight at 4°C with a antibody
|
5) |
Antibody binding was visualized by the avidin-biotin-immuno
peroxidase |
6) |
3,3-Diaminobenzidine tetrahydrochloride was used as the chromogen. |
7) |
Hematoxylin or Eosin was used as the counter stain.
|
Technical Note |
|
1) |
Sections from which the primary antibodies were
omitted served |
2) |
For frozen materials, samples were fixed in 10%
formalin, immersed |
3) |
For paraffin embedded materials, samples were fixed in 10% formalin, dehydrated, embedded in paraffin, and stored at room temperature. |
4) |
Microwave treatment improves the target staining,
whereas it declines |
5) |
Protease K treatment declines the target staining. |
Positive control
Aortic wall in the renal tissue of diabetic nephropathy or aortic wall
of atherosclerosis.
REFERENCES
1) |
Protein modification by a Maillard reaction intermediate
methylglyoxal. Immunochemical detection of fluorescent 5-methylimidazolone
derivatives in vivo. |
2) |
Methylglyoxal Modification of Protein -Chemical
and Immunochemical Characterization of Methylglyoxal-Arginine Adduct. |
3) |
Advanced glycation and lipidoxidation of the peritoneal
membrane: respective roles of serum and peritoneal fluid reactive
carbonyl compounds. |
4) |
Argpyrimidine, a blue fluorophore in human lens
proteins: high levels in brunescent cataractous lenses. |
5) |
High concentrations of glucose induce synthesis
of argpyrimidine in retinal endothelial cells. |
6) |
Curcumin Inhibits ROS Formation and Apoptosis in
Methylglyoxal- Treated Human Hepatoma G2 Cells. |
The ‘Anti-MMG Monoclonal Antibody’ is
manufactured in Japan
by the Life Science Products Division of the
Nippon Oils
and Fats
Corporation, Japan. Genox is the distributor of this product
for users in North and South
America.
Note: Genox’s Products are
for RESEARCH USE ONLY.
Users of Genox’s
products are strongly advised NOT TO USE THEM FOR CLINICAL/DIAGNOSTIC
APPLICATIONS.
The provision of test reports, generated
by using Genox's products, to individuals
or to
treating physicians for the diagnosis, prevention,
treatment and control of any human disease or impairment
of, or the assessment of the health, nutritional,
or medical condition of individuals is expressly
prohibited by law. 42
U.S.C. § 263a (2006); 42 C.F.R. § 493.3
(2006); COMAR 10.10.01.02 (2006). Genox
is not a CLIA certified laboratory.
© Copyright 1996-2010 Genox Corporation. All rights reserved.

